Mazumdar Shaw Medical Centre (MSMC), Bengaluru operationalized the New Bone Marrow Transplant (BMT) Wing in Q4 FY23 taking the total BMT bed capacity to 35, making it the largest facility in India. Department of Orthopaedics, Spine & Trauma has successfully performed a complex Hand Replantation Surgery in the quarter; the Unit also has to its credit 8 Renal Transplant, 7 Liver Transplant, 63 BMT & 76 Robotic Surgeries during the quarter;
Rabindranath Tagore International Institute of Cardiac Sciences (RTIICS), Kolkata successfully installed and commissioned the Lab Automation - TRAC System
Dharamshila Narayana Super Speciality Hospital, Delhi upgraded Elekta Synergy to Versa HD Platform in the quarter
NH Jaipur successfully commissioned the LINAC Machine during the fourth quarter of the current fiscal year
Narayana Institute of Cardiac Sciences (NICS), Bengaluru successfully performed 2,159 Cardiac Surgical procedures, 5,243 Interventional Cardiology procedures, 146 Minimally Invasive Cardiac Surgical segment and 38 TAVI in Q4 FY23; Achieved the highest ever monthly surgical volumes of 770 & Cath Lab case volumes of 1,874 in Mar'23.
Financial
Performance
Consolidated operating revenues of INR 12,216 mn in Q4 FY23 translating into INR 45,248 mn in FY23
Consolidated EBITDA of INR 2,904(1) mn in Q4 FY23 at margin of 23.8%, translating into EBITDA of INR 10,313(1) mn in FY 23 at 22.8% and consolidated PAT of INR 1,732(2) mn for Q4 FY 23, translating into PAT of INR 6,066(2) mn for FY 23
Consolidated Total Borrowings less Cash & Bank Balance and Current Investments of INR 1,310 mn as on 31st March 2023, ie net debt to equity ratio of 0.06 (Out of which, debt worth US$ 32 mn is foreign currency denominated)
As per the accounting treatment for leases per IND AS 116 effective 1st April 2019 which resulted in INR 154 mn increase in EBITDA for Q4 FY23 and INR 563 mn increase in FY23
(2) As per the accounting treatment for leases per IND AS 116 effective 1st April 2019 which resulted in INR 0.3 mn decrease in PAT for Q4 FY23 and INR 8.0 mn increase in FY23
4
Attachments
Original Link
Original Document
Permalink
Disclaimer
Narayana Hrudayalaya Ltd. published this content on 20 May 2023 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 20 May 2023 04:19:04 UTC.
Narayana Hrudayalaya Limited is an India-based healthcare service provider, operating a chain of multispecialty, tertiary, and primary healthcare facilities. The Company is primarily engaged in the business of rendering medical and healthcare services. It has a network of multispecialty and super specialty hospitals spread across multiple locations. The Company owns and operates certain hospitals. Its medical services include anesthesia, blood bank, bone marrow transplant (stem cell transplant), breast cancer, electrophysiology, emergency medicine, endocrinology, family medicine, gastrointestinal oncology, general surgery, geriatrics, gynecology - oncology, pulmonology, radiation oncology, hematology, heart transplant, hepatology liver transplantation and infectious diseases. The Company has a network of approximately 19 hospitals and three heart centers across India along with overseas presence at Cayman Islands, with over 5,860 operational beds and a capacity of over 6,160 beds.
NARAYANA HRUDAYALAYA LIMITED 
